SCHEMBL900117

SCHEMBL900117

Clc1ccc(C2C[CH]C2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3A P46098 1/20 0.50
SLC6A2 P23975 1/20 0.50
SLC6A3 Q01959 1/20 0.50
LMNA P02545 1/20 0.44
CYP2A6 P11509 1/20 0.44
ALDH1A1 P00352 1/20 0.44
POLB P06746 1/20 0.44
ALOX12 P18054 1/20 0.44
HTT P42858 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
HSD17B10 Q99714 1/20 0.44
DRD2 P14416 1/20 0.44
SRD5A1 P18405 2/20 0.41
ADRA1A P35348 1/20 0.40
MAP1LC3B Q9GZQ8 1/20 0.40
SLC18A3 Q16572 1/20 0.40
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9517400 0.85 HTR3A (0.48) HTR3ASLC6A2SLC6A3LMNACYP2A6
SCHEMBL9517403 0.85 HTR3A (0.48) HTR3ASLC6A2SLC6A3LMNACYP2A6
SCHEMBL315186 0.80 HTR3A (0.58) HTR3ASLC6A2SLC6A3LMNACYP2A6
SCHEMBL694010 0.77 HTR3A (0.50) HTR3ASLC6A2SLC6A3LMNACYP2A6
SCHEMBL4038924 0.76 KDM1A (0.44) SLC6A2SLC6A3DRD2MAP1LC3BHTR2A
SCHEMBL218475 0.76 HTR3A (0.59) HTR3ASLC6A2SLC6A3LMNACYP2A6
SCHEMBL9517943 0.76 ACHE (0.42) LMNAALDH1A1POLBALOX12HTT
SCHEMBL435619 0.76 HTR3A (0.59) HTR3ASLC6A2SLC6A3LMNACYP2A6
SCHEMBL2013478 0.74 SLC18A3 (0.48) SLC6A2SLC6A3LMNACYP2A6HSD17B10
SCHEMBL655216 0.74 HTR3A (0.43) HTR3ASLC6A2SLC6A3LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012044567-A2 IMIDAZOLE DERIVATIVES MERCK SHARP & DOHME CORP. (US) 2012-04-05 WO disclosed